Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 1;198(1):13-23.
doi: 10.1164/rccm.201801-0062UP.

Update in Pulmonary Vascular Disease 2016 and 2017

Affiliations

Update in Pulmonary Vascular Disease 2016 and 2017

Evan L Brittain et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Novel molecular and cellular insights into pulmonary arterial hypertension signaling reveals convergence of sex hormone, glucose metabolism, and inflammatory signaling on common effectors of the BMP (bone morphogenetic protein)/TGF-β (transforming growth factor) and PPAR-γ (peroxisome proliferator-activated receptor-γ) axes and other signaling axes. The yellow numbers indicate references. Illustration by Jacqueline Schaffer. 16α-OHE1 = 16α hydroxyestrone 1; ADAM = a disintegrin and metalloprotease; ALK = activin-like kinase; BMPR2 = BMP receptor type 2; DHEA = dehydroepiandrosterone; DHEA-S = dehydroepiandrosterone sulfate; ERα = estrogen receptor α; Fc = fragment crystallizable region; FK506 = tacrolimus; FKBP12 = FK506 binding protein; miR = microRNA; PAEC = pulmonary artery endothelial cell; PASMC = pulmonary artery smooth muscle cell; p-SMAD = phosphorylated SMAD; SMAD = fusion of Caenorhabditis elegans Sma genes and the Drosophila Mad, Mothers against decapentaplegic; SMURF1 = E3 ubiquitin-protein ligase SMURF1; TAZ = transcriptional co-activator with PDZ-binding motif; TGF-β1 = transforming growth factor β-1; TGF-β1R = TGF-β1 receptor; TNFα = tumor necrosis factor α; VEGFR3 = vascular endothelial growth factor receptor 3; YAP = Yes-8 associated protein.

References

    1. Gladwin MT. Translational advances in the field of pulmonary hypertension bench to bedside: how fundamental discoveries in science are advancing our understanding and therapy of pulmonary arterial hypertension. Am J Respir Crit Care Med. 2017;195:1–3. - PMC - PubMed
    1. Ventetuolo CE, Baird GL, Barr RG, Bluemke DA, Fritz JS, Hill NS, et al. Higher estradiol and lower dehydroepiandrosterone-sulfate levels are associated with pulmonary arterial hypertension in men. Am J Respir Crit Care Med. 2016;193:1168–1175. - PMC - PubMed
    1. Rhodes CJ, Ghataorhe P, Wharton J, Rue-Albrecht KC, Hadinnapola C, Watson G, et al. Plasma metabolomics implicates modified transfer RNAs and altered bioenergetics in the outcomes of pulmonary arterial hypertension. Circulation. 2017;135:460–475. - PMC - PubMed
    1. Chen X, Austin ED, Talati M, Fessel JP, Farber-Eger EH, Brittain EL, et al. Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects. Eur Respir J. 2017;50:1602337. - PMC - PubMed
    1. Dean A, Gregorc T, Docherty CK, Harvey KY, Nilsen M, Morrell NW, et al. Role of the aryl hydrocarbon receptor in Sugen 5416–induced experimental pulmonary hypertension. Am J Respir Cell Mol Biol. 2018;58:320–330. - PMC - PubMed

Publication types

MeSH terms